European Journal of Cancer
Volume 46, Issue 18 , Pages 3219-3232 , December 2010

Meta-analysis of the impact of surgical margins on local recurrence in women with early-stage invasive breast cancer treated with breast-conserving therapy

  • Nehmat Houssami

      Affiliations

    • Screening and Test Evaluation Program (STEP), School of Public Health, Sydney Medical School, University of Sydney, Sydney, Australia
    • Corresponding Author InformationCorresponding author: Address: School of Public Health (A27), Sydney Medical School, University of Sydney, Sydney 2006, Australia. Tel.: +61 (0) 419 273510; fax +61 (0) 2 9705 1046.
    • ,
  • Petra Macaskill

      Affiliations

    • Screening and Test Evaluation Program (STEP), School of Public Health, Sydney Medical School, University of Sydney, Sydney, Australia
    • ,
  • M. Luke Marinovich

      Affiliations

    • Screening and Test Evaluation Program (STEP), School of Public Health, Sydney Medical School, University of Sydney, Sydney, Australia
    • ,
  • J. Michael Dixon

      Affiliations

    • Breakthrough Research Unit Edinburgh, Western General Hospital, Edinburgh, Scotland, United Kingdom
    • ,
  • Les Irwig

      Affiliations

    • Screening and Test Evaluation Program (STEP), School of Public Health, Sydney Medical School, University of Sydney, Sydney, Australia
    • ,
  • Meagan E. Brennan

      Affiliations

    • Screening and Test Evaluation Program (STEP), School of Public Health, Sydney Medical School, University of Sydney, Sydney, Australia
    • ,
  • Lawrence J. Solin

      Affiliations

    • Department of Radiation Oncology, Albert Einstein Medical Center, Philadelphia, PA, USA

Received 8 July 2010 ,Revised 26 July 2010 ,Accepted 28 July 2010.

References 

  1. Veronesi U, Cascinelli N, Mariani L, et al. Twenty-year follow-up of a randomized study comparing breast-conserving surgery with radical mastectomy for early breast cancer. New Engl J Med. 2002;347:1227–1232
  2. Fisher B, Anderson S, Bryant J, et al. Twenty-year follow-up of a randomized trial comparing total mastectomy, lumpectomy, and lumpectomy plus irradiation for the treatment of invasive breast cancer. New Engl J Med. 2002;347:1233–1241
  3. Van Dongen JA, Voogd AC, Fentiman IS, et al. Long-term results of a randomized trial comparing breast-conserving therapy with mastectomy: European Organization for Research and Treatment of Cancer 10801 trial. J Natl Cancer Inst. 2000;92:1143–1150
  4. Poggi MM, Danforth DN, Sciuto LC, et al. Eighteen-year results in the treatment of early breast carcinoma with mastectomy versus breast conservation therapy: the National Cancer Institute Randomized Trial. Cancer. 2003;98:697–702
  5. Blichert-Toft M, Rose C, Andersen JA, et al. Danish randomized trial comparing breast conservation therapy with mastectomy: six years of life-table analysis. Danish Breast Cancer Cooperative Group. J Natl Cancer Inst Monographs. 1992;(11):19–25
  6. Clarke M, Collins R, Darby S, et al. Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: an overview of the randomised trials. Lancet. 2005;366:2087–2106
  7. Newman LA, Kuerer HM. Advances in breast conservation therapy. J Clin Oncol. 2005;23:1685–1697
  8. Morrow M, Strom EA, Bassett LW, et al. Standard for breast conservation therapy in the management of invasive breast carcinoma. CA: Cancer J Clin. 2002;52:277–300
  9. Al-Ghazal SK, Fallowfield L, Blamey RW. Comparison of psychological aspects and patient satisfaction following breast conserving surgery, simple mastectomy and breast reconstruction. Eur J Cancer. 2000;36:1938–1943
  10. Singletary SE. Surgical margins in patients with early-stage breast cancer treated with breast conservation therapy. Am J Surg. 2002;184:383–393
  11. Carlson RW, Allred DC, Anderson BO, et al. Breast cancer. Clinical practice guidelines in oncology. J Natl Comprehens Cancer Network. 2009;7:122–192
  12. Schwartz GF, Veronesi U, Clough KB, et al. Consensus conference on breast conservation. J Am Coll Surg. 2006;203:198–207
  13. Morrow M. Margins in breast-conserving therapy: have we lost sight of the big picture?. Expert Rev Anticancer Therapy. 2008;8:1193–1196
  14. Luini A, Rososchansky J, Gatti G, et al. The surgical margin status after breast-conserving surgery: discussion of an open issue. Breast Cancer Res Treat. 2009;113:397–402
  15. MacDonald S, Taghian AG. Prognostic factors for local control after breast conservation: does margin status still matter?. J Clin Oncol. 2009;27:4929–4930
  16. Zavagno G, Goldin E, Mencarelli R, et al. Role of resection margins in patients treated with breast conservation surgery. Cancer. 2008;112:1923–1931
  17. Taghian A, Mohiuddin M, Jagsi R, Goldberg S, Ceilley E, Powell S. Current perceptions regarding surgical margin status after breast-conserving therapy: results of a survey. Ann Surg. 2005;241:629–639
  18. Sakamoto G, Inaji H, Akiyama F, et al. General rules for clinical and pathological recording of breast cancer. Breast Cancer. 2005;12(Suppl.):27
  19. Goldstein NS, Kestin L, Vicini F. Factors associated with ipsilateral breast failure and distant metastases in patients with invasive breast carcinoma treated with breast-conserving therapy: a clinicopathologic study of 607 neoplasms from 583 patients. Am J Clin Pathol. 2003;120:500–527
  20. Neuschatz AC, DiPetrillo T, Safaii H, et al. Long-term follow-up of a prospective policy of margin-directed radiation dose escalation in breast-conserving therapy. Cancer. 2003;97:30–39
  21. Park CC, Mitsumori M, Nixon A, et al. Outcome at 8 years after breast-conserving surgery and radiation therapy for invasive breast cancer: influence of margin status and systemic therapy on local recurrence. J Clin Oncol. 2000;18:1668–1675
  22. Altman DG. Systematic reviews of evaluations of prognostic variables. In:  Egger M,  Smith GD,  Altman DG editor. Systematic reviews in health care: meta-analysis in context. 2nd ed.. London: BMJ Publishing Group; 2001;p. 228–247
  23. Randolph A, Bucher H, Richardson WS, et al. In:  Guyatt G,  Rennie D editor. Users’ guide to the medical literature. A manual for evidence-based clinical practice. Chicago: AMA Press; 2002;p. 141–154
  24. Freedman G, Fowble B, Hanlon A, et al. Patients with early stage invasive cancer with close or positive margins treated with conservative surgery and radiation have an increased risk of breast recurrence that is delayed by adjuvant systemic therapy. Int J Radiat Oncol Biol Phys. 1999;44:1005–1015
  25. Obedian E, Haffty B. Negative margin status improves local control in conservatively managed breast cancer patients. Cancer Journal from Scientific American. 1999;6:28–33
  26. Touboul E, Buffat L, Belkacemi Y, et al. Local recurrences and distant metastases after breast-conserving surgery and radiation therapy for early breast cancer. Int J Radiat Oncol Biol Phys. 1999;43:25–38
  27. Kokubo M, Mitsumori M, Ishikura S, et al. Results of breast-conserving therapy for early stage breast cancer: Kyoto university experiences. Am J Clin Oncol Cancer Clin Trials. 2000;23:499–505
  28. Voogd AC, Nielsen M, Peterse JL, et al. Differences in risk factors for local and distant recurrence after breast-conserving therapy or mastectomy for stage I and II breast cancer: pooled results of two large European randomized trials. J Clin Oncol. 2001;19:1688–1697
  29. Horiguchi J, Koibuchi Y, Takei H, et al. Breast-conserving surgery following radiation therapy of 50 Gy in stages I and II carcinoma of the breast: the experience at one institute in Japan. Oncol Rep. 2002;9:1053–1057
  30. Mirza NQ, Vlastos G, Meric F, et al. Predictors of locoregional recurrence among patients with early-stage breast cancer treated with breast-conserving therapy. Ann Surg Oncol. 2002;9:256–265
  31. Karasawa K, Obara T, Shimizu T, et al. Outcome of breast-conserving therapy in the Tokyo Women’s Medical University Breast Cancer Society experience. Breast Cancer. 2003;10:241–248
  32. Perez CA. Conservation therapy in T1–T2 breast cancer: past, current issues, and future challenges and opportunities. Cancer J. 2003;9:442–453
  33. Smitt MC, Nowels K, Carlson RW, Jeffrey SS. Predictors of reexcision findings and recurrence after breast conservation. Int J Radiat Oncol Biol Phys. 2003;57:979–985
  34. Santiago RJ, Wu L, Harris E, et al. Fifteen-year results of breast-conserving surgery and definitive irradiation for Stage I and II breast carcinoma: the University of Pennsylvania experience. Int J Radiat Oncol Biol Phys. 2004;58:233–240
  35. Bellon JR, Come SE, Gelman RS, et al. Sequencing of chemotherapy and radiation therapy in early-stage breast cancer: updated results of a prospective randomized trial. J Clin Oncol. 2005;23:1934–1940
  36. Karasawa K, Mitsumori M, Yamauchi C, et al. Treatment outcome of breast-conserving therapy in patients with positive or close resection margins: Japanese multi institute survey for radiation dose effect. Breast Cancer. 2005;12:91–98
  37. Kunos C, Latson L, Overmoyer B, et al. Breast conservation surgery achieving > or =2mm tumor-free margins results in decreased local–regional recurrence rates. Breast J. 2006;12:28–36
  38. Vujovic O, Cherian A, Yu E, et al. The effect of timing of radiotherapy after breast-conserving surgery in patients with positive or close resection margins, young age, and node-negative disease, with long term follow-up. Int J Radiat Oncol Biol Phys. 2006;66:687–690
  39. Ewertz M, Moe Kempel M, During M, et al. Breast conserving treatment in Denmark, 1989–1998. A nationwide population-based study of the Danish Breast Cancer Co-operative Group. Acta Oncol. 2008;47:682–690
  40. Kreike B, Hart AAM, van de Velde T, et al. Continuing risk of ipsilateral breast relapse after breast-conserving therapy at long-term follow-up. Int J Radiat Oncol Biol Phys. 2008;71:1014–1021
  41. Varghese P, Gattuso JM, Mostafa AIH, et al. The role of radiotherapy in treating small early invasive breast cancer. Eur J Surg Oncol. 2008;34:369–376
  42. Freedman GM, Hanlon AL, Fowble BL, Anderson PR, Nicolaou N. Recursive partitioning identifies patients at high and low risk for ipsilateral tumor recurrence after breast-conserving surgery and radiation. J Clin Oncol. 2002;20:4015–4021
  43. Schnitt SJ, Abner A, Gelman R, et al. The relationship between microscopic margins of resection and the risk of local recurrence in patients with breast cancer treated with breast-conserving surgery and radiation therapy. Cancer. 1994;74:1746–1751
  44. Gage I, Schnitt SJ, Nixon AJ, et al. Pathologic margin involvement and the risk of recurrence in patients treated with breast-conserving therapy. Cancer. 1996;78:1921–1928
  45. Cabioglu N, Hunt KK, Buchholz TA, et al. Improving local control with breast-conserving therapy: a 27-year single-institution experience. Cancer. 2005;104:20–29
  46. Horiguchi J, Iino Y, Takei H, et al. Surgical margin and breast recurrence after breast-conserving therapy. Oncol Rep. 1999;6:135–138
  47. Wazer DE, Schmidt-Ullrich RK, Ruthazer R, et al. Factors determining outcome for breast-conserving irradiation with margin-directed dose escalation to the tumor bed. Int J Radiat Oncol Biol Phys. 1998;40:851–858
  48. Smitt MC, Nowels KW, Zdeblick MJ, et al. The importance of the lumpectomy surgical margin status in long-term results of breast conservation. Cancer. 1995;76:259–267
  49. Solin LJ, Fowble BL, Schultz DJ, Goodman RL. The significance of the pathology margins of the tumor excision on the outcome of patients treated with definitive irradiation for early stage breast cancer. Int J Radiat Oncol Biol Phys. 1991;21:279–287
  50. Peterson ME, Schultz DJ, Reynolds C, Solin LJ. Outcomes in breast cancer patients relative to margin status after treatment with breast-conserving surgery and radiation therapy: The University of Pennsylvania experience. Int J Radiat Oncol Biol Phys. 1999;43:1029–1035
  51. Recht A, Come SE, Henderson IC, et al. The sequencing of chemotherapy and radiation therapy after conservative surgery for early-stage breast cancer. New Engl J Med. 1996;334:1356–1361
  52. Borger J, Kemperman H, Hart A, et al. Risk factors in breast-conservation therapy. J Clin Oncol. 1994;12:653–660
  53. Kini VR, White JR, Horwitz EM, et al. Long term results with breast-conserving therapy for patients with early stage breast carcinoma in a community hospital setting. Cancer. 1998;82:127–133
  54. DiBiase SJ, Komarnicky LT, Heron DE, Schwartz GF, Mansfield CM. Influence of radiation dose on positive surgical margins in women undergoing breast conservation therapy. Int J Radiat Oncol Biol Phys. 2002;53:680–686
  55. Tartter PI, Kaplan J, Bleiweis I, et al. Lumpectomy margins, reexcision, and local recurrence of breast cancer. Am J Surg. 2000;179:81–85
  56. Renton SC, Gazet JC, Ford HT, Corbishley C, Sutcliffe R. The importance of the resection margin in conservative surgery for breast cancer. Eur J Surg Oncol. 1996;22:17–22
  57. Truong PT, Jones SO, Kader HA, et al. Patients with t1 to t2 breast cancer with one to three positive nodes have higher local and regional recurrence risks compared with node-negative patients after breast-conserving surgery and whole-breast radiotherapy. Int J Radiat Oncol Biol Phys. 2009;73:357–364
  58. Poortmans PM, Collette L, Horiot JC, et al. Impact of the boost dose of 10 Gy versus 26 Gy in patients with early stage breast cancer after a microscopically incomplete lumpectomy: 10-year results of the randomised EORTC boost trial. Radiother Oncol. 2009;90:80–85
  59. Pittinger TP, Maronian NC, Poulter CA, et al. Importance of margin status in outcome of breast-conserving surgery for carcinoma. Surgery. 1994;116:605–609
  60. Yau TK, Soong IS, Chan K, et al. Clinical outcome of breast conservation therapy for breast cancer in Hong Kong: prognostic impact of ipsilateral breast tumor recurrence and 2005 St. gallen risk categories. Int J Radiat Oncol Biol Phys. 2007;68:667–672
  61. Bollet MA, Sigal-Zafrani B, Mazeau V, et al. Age remains the first prognostic factor for loco-regional breast cancer recurrence in young (<40 years) women treated with breast conserving surgery first. Radiother Oncol. 2007;82:272–280
  62. Hardy K, Fradette K, Gheorghe R, Lucman L, Latosinsky S. The impact of margin status on local recurrence following breast conserving therapy for invasive carcinoma in Manitoba. J Surg Oncol. 2008;98:399–402
  63. Rauschecker HF, Sauerbrei W, Gatzemeier W, et al. Eight-year results of a prospective non-randomised study on therapy of small breast cancer. The German Breast Cancer Study Group (GBSG). Eur J Cancer. 1998;34:315–323
  64. Jones HA, Antonini N, Hart AA, et al. Impact of pathological characteristics on local relapse after breast-conserving therapy: a subgroup analysis of the EORTC boost versus no boost trial. J Clin Oncol. 2009;27:4939–4947
  65. Yoshida T, Takei H, Kurosumi M, et al. Ipsilateral breast tumor relapse after breast conserving surgery in women with breast cancer. Breast. 2009;18:238–243
  66. Kaufmann M, Morrow M, von Minckwitz G, Harris JR Biedenkopf Expert Panel Members. Locoregional treatment of primary breast cancer: consensus recommendations from an International Expert Panel. Cancer. 2010;116:1184–1191
  67. Coates AS, Keshaviah A, Thurlimann B, et al. Five years of letrozole compared with tamoxifen as initial adjuvant therapy for postmenopausal women with endocrine-responsive early breast cancer: update of study BIG 1–98. J Clin Oncol. 2007;25:486–492
  68. Coombes RC, Hall E, Gibson LJ, et al. A randomized trial of exemestane after two to three years of tamoxifen therapy in postmenopausal women with primary breast cancer. New Engl J Med. 2004;350:1081–1092
  69. Romond EH, Perez EA, Bryant J, et al. Trastuzumab plus adjuvant chemotherapy for operable HER2-positive breast cancer. New Engl J Med. 2005;353:1673–1684
  70. Smith I, Procter M, Gelber RD, et al. 2-year follow-up of trastuzumab after adjuvant chemotherapy in HER2-positive breast cancer: a randomised controlled trial. Lancet. 2007;369:29–36
  71. Lagios MD. Multicentricity of breast carcinoma demonstrated by routine correlated serial subgross and radiographic examination. Cancer. 1977;40:1726–1734
  72. Holland R, Veling SH, Mravunac M, Hendriks JH. Histologic multifocality of Tis, T1–2 breast carcinomas. Implications for clinical trials of breast-conserving surgery. Cancer. 1985;56:979–990
  73. Pass H, Vicini FA, Kestin LL, et al. Changes in management techniques and patterns of disease recurrence over time in patients with breast carcinoma treated with breast-conserving therapy at a single institution. Cancer. 2004;101:713–720
  74. Moher D, Liberati A, Tetzlaff J, Altman DG, The PRISMA Group. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement 2009. PLoS Med 6(6), doi:10.1371/journal.pmed1000097.

☆ This work was partly funded by the National Health and Medical Research Council (NHMRC) program grant 402764 to the Screening & Test Evaluation Program.

PII: S0959-8049(10)00753-7

doi: 10.1016/j.ejca.2010.07.043

European Journal of Cancer
Volume 46, Issue 18 , Pages 3219-3232 , December 2010

Article Tools

* Image Usage & Resolution